Quote from: Richenda on June 18, 2016, 08:02:26 PMI can well believe that estrogen can act as a powerful anti androgen. It's a shame that there aren't long term studies on this.
Long term studies are not needed to confirm what is basic science, that high enough estrogen and/or progesterone levels in the blood will shut down signal to gonads through negative feedback inhibition and cease production of T. Injections are available today and many transwomen take them, including myself.
QuoteRe my earlier post I also think in blood tests we possibly get fixated on T levels when it's DHT that is 9x more powerful. Drugs like Dutasteride, Finasteride and Bicalutamide effectively block the latter not the former.
Bicalutamide blocks ALL androgens and that means both testosterone and DHT, while finasteride and dutasteride inhibit enzyme(s) responsible for T to DHT conversion, therefore reducing DHT concentrations ONLY.
QuoteI lactate daily.
This can possibly indicate a prolactinoma, a benign pituitary tumor. Breast stimulation can also lead to galactorrhea. To determine if this is indeed a prolactinoma, doctors usually check prolactin levels and do an MRI. In transsexual women, prolactinomas were reported in those taking cyproterone acetate and/or non bio-identical estrogen/progestogen.
QuoteAnyway, I've pretty much decided I'm having an orchiectomy next month. That will take care of the T issue as it wipes out 95% of testosterone. In theory I might continue on a much reduced dose of finasteride but it's going to be important to watch for osteoporosis.
Osteoporosis is prevented by a small amount of estrogen. To maintain female characteristics, health (physical and psychological), energy and youth (slow down ageing), some E is needed post-op.
Quote from: anjaq on June 19, 2016, 04:25:34 AM
Did you know that a woman has usually more Testosterone than Estrogen in her body?
Regardless, the end result is feminization of the body. And it also depends on where she is in her cycle or if she is pregnant. 1 ng/dl (usual units for T, in the US) = 10 pg/ml (usual units for E, in the US). So, if a woman has 600 pg/ml estradiol (mid-cycle), it's equal to 60 ng/dl and T may well be under that...during pregnancy, estradiol can go up to 75,000, hence 7,500 ng/dl, well above testosterone levels.
QuoteAnd younger women have more than older men?
http://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/83686Lowest total testosterone in adult men is 240 ng/dl, highest 75 ng/dl in women.
Lowest free testosterone in adult men is 2.29 ng/dl (at 95/100+ years) vs. 1.08-1.09 ng/dl in young women (15-18 yrs, 20-25 yrs)
Same pattern for bio-testosterone.
According to this source, young women do NOT have more testosterone than older men, be it TOTAL, FREE or BIO-AVAILABLE.
http://www.healthtestingcenters.com/testosterone-free-total.aspxMen 270-1070 ng/dL (9-38 nmol/L)
Women 15-70 ng/dL (0.52-2.4 nmol/L)
Men 50-210 pg/mL (174-729 pmol/L)
Women 1.0-8.5 pg/mL (3.5-29.5 pmol/L)
So again, according to this source, the lowest in men is still much above female range.
QuoteIts really fascinating once you look into it. The distinction of Testosterone = Man and Estrogen = Woman is a fairytale, both hormones exist in both and are needed in both.
But, to different degrees so men masculinize and women feminize.
QuoteHowever the glands do not care if it is testosterone or estrogen.
Or progesterone and hence, most progestins...why cyproterone acetate and medroxyprogesterone acetate reduce T, LH and FSH.
QuoteFor women it is more complex but essentially also there more estrogen and progesterone in the blood means less LH and FSH and thus a downregulation of internal hormone production.
In women, there is actually a positive feedback mechanism whereby estrogen, during the follicular phase, actually increases LH and FSH production (up to a critical point) leading to even more estrogen and ovulation induction.
QuoteNow what many trans women seem to seek however is demaskulinization - no libido and erections anymore
I never aimed for no libido and thankfully, have plenty of it on E and P despite low T values (around 8 ng/dl, free T undetectable), under normal female range. Perhaps not as intense but this also depends.

Quoteremember also women have a libido and life without it is not that great and that testosterone is also important for muscle growth (including growing new muscles in a more feminine shape) and many other body functions. When yout pubic hair starts to become very thin, its a warning sign, since only old and very young women have little pubic hair (unless you remove it of course
)
Again, despite my very low T, I have thick, dark, dense pubic hair and not much muscle mass has been lost. I can still see my abs.
QuoteAntiandrogens are known to increase the prolactin, especially Androcur which can cause Prolactinoma, a tumor of the pituary gland that produces prolactin.
The only anti-androgen associated (no causal effect established, to be fair) with prolactinoma is cyproterone acetate. Other anti-androgens do not raise prolactin levels.
QuoteLast but not least - be very careful with long term use of DHT blockers. There are massive reports about ill side effects of this. Google it. It can even cause some slight forms of dementia. Again, blocking out all and every "androgen" in the body is counterproductive as the female body also needs some of those hormones.
Were these effects observed in individuals with no hormone replacement in the form of estrogen to prevent dementia? Some inviduals, born XY, completely androgen insensitive, do fine without ANY androgen so I question the importance of it for normal functioning if E is high enough to compensate for it.
QuoteAlso be aware that progesterone is a soft DHT inhibitor.
The only study to have shown this was an in-vitro study where concentrations of progesterone were supraphysiological, way above what we can reach. I also question this claim for this reason.
QuoteI and some others I know use Progesterone Gel on the temples and top of the head and it regeneratesd hair growth as it also reduces DHT production. (it is a 5 alpha reductase inhibitor).
Were serum or scalp DHT levels reduced after the use of the gel? Could these results have occurred anyways, if gel hadn't been used? We need hard proof to make claims such as these.
Quote from: Richenda on June 19, 2016, 06:44:19 AM
However, I do confess to being slightly anxious over the idea of high dosage anything, including estrogen.
1)
Cardiovascular and clotting risks . Ciswomen are reported to be much less affected than men by cardiovascular complications despite pregnancy levels of estradiol and levels of up to 650 pg/ml every menstrual cycle. Their risks increase (and approach that of males) at around menopause when estrogen levels DROP. Studies have strongly suggested a protective role for estrogen. I can provide these studies.
. Studies in men with prostate cancer (ages 49-91) have shown that estradiol levels up to approx. 700 pg/ml were safe.
There were no cardiovascular complications or incidences of thrombosis. In fact, researchers stated high levels could be PROTECTIVE. Additionally, it was observed that estrogen improved lipid profiles, without cardiovascular deterioration and that it may improve cardiovascular disease and mortality, long-term. These men were treated with high dose injectable or transdermal (patches) estradiol. I can provide you those studies.
. Pregnant women have levels that go as high as 75,000 pg/ml and yet the risk of having a DVT or pulmonary embolism is less than 0.02 % with thromboembolism being 5 times as more likely post-partum (when levels drop) and pulmonary embolism being extremely rare during pregnancy and more common post-partum (when levels drop). I can provide you the evidence as well.
. Four studies show circulating levels of estradiol not to be a useful criterion of risk of thrombosis, as despite high levels, no increased risk was found AND rather the route of administration/type of estrogen is more indicative of the risk. Here, two of them.
Am J Obstet Gynecol. 1993 Dec;169(6):1549-53.
Fibrinolytic parameters in women undergoing ovulation induction."As serum estradiol levels increased throughout each phase (maximum mean estradiol 739.8 pg/ml)"
"Down-regulation of the fibrinolytic system was observed as estradiol levels increased. However, thrombin formation did not change, thus suggesting that
elevated circulating estradiol alone does not predispose to a thromboembolic event."
Br J Obstet Gynaecol. 1990 Oct;97(10):917-21."There is some anxiety about the possible harmful sequelae of supraphysiological estradiol levels but no data are currently available to show any deleterious effects of these levels on coagulation factors, blood pressure, glucose tolerance or the occurrences of endometrial or breast cancer (Hammond et al. 1974; Thom et id. 1978; Studd B Thom 1981; Armstrong 1988)."
. Arch Sex Behav. 1998 Oct;27(5):475-92. In this study, transsexual women were given high dose intramuscular E and some were prescribed medium-high doses of oral E. In spite of this, there was not one incidence of thrombosis.
"None of our patients developed deep vein thrombosis or embolism during cross-gender hormone therapy performed in our clinic."
2)
Breast cancer risk. In transsexual women, breast cancer incidence is very low, close to that of men not on HRT and significantly lower relative to ciswomen (as per Dr. Gooren and his team, leading specialists of HRT treatment in transwomen). Only 17 cases reported since 1968 despite decades of very aggressive, high doses of oral estrogens and non-oral estrogens (intramuscular). Only one proven case reported in Holland among Gooren's patients in decades of treatment despite high doses of E for several years. Studies to support this.
. In men with prostate cancer treated with high dose estrogen over the years, since the 1960's, breast cancer is extremely rare. Supporting evidence.
. High dose estrogen has actually been used to treat ciswomen afflicted with breast cancer, in one instance, with increased effectiveness relative to tamoxifen, one of the drugs of choice in its treatment.
. The incidence of breast cancer from one country to another were not found to be correlated with levels of estrogens. In fact, the only significant finding was a higher level of estradiol in a subpopulation (adolescents) of the country (during the luteal phase) with the least incidence of breast cancer.
. The more childbirths a woman (hence, the more pregnancies when levels of E are sky high), the lower the risk of breast cancer. On the other hand, celibate nuns are historically known to have a higher incidence of breast cancer risk, going as far back as the 1700's.
. Breast cancer risk is highest in women over the age of 40 and especially 50,
when estrogen levels drop.
. Studies in mice and observations that carcinoma incidence is increased post-pregnancy suggest high levels of estradiol are protective.
3)
Uterine cancer risk. YOU HAVE NO UTERUS
4)
Prolactinoma. Ciswomen have very high levels of prolactin, up to 600 ng/ml (ug/L), during pregnancy and continue to have high levels during breastfeeding which can sometimes last a few years. Despite this, the fact that estradiol levels can also peak quite high during a menstrual cycle (up to 650 pg/ml) and women's history of taking birth control pills or HRT involving estrogens that strongly affect pituitary gland, the prevalence of prolactinoma has been estimated to be 0.1% in women. Doctors/health authorities do not ask mothers to stop breastfeeding their children or not become pregnant again due to risk of prolactinoma.
. Causation has not been established between the use of estrogen or pregnancy and prolactinoma in women. Association between OC/HRT use and prolactinoma may have more to do with the increased likelihood that women with prolactinoma use treatment to regulate menstrual cycle disrupted by prolactinoma.
. There is a negligible impact of either birth control pills, HRT or pregnancy (when E levels are very high) on small pituitary adenoma in women. Pregnancy has even shown to have a favorable effect on microadenomas with spontaneous remission ranging from 17-35% (Presse Med, 17 (1998), pp. 2117–2119) vs. 13-15% in those who have not undergone pregnancy. From J Clin Endocrinol Metab. 2007 Aug; 92( 8 ):2861-5.
"Changes in tumor vasculature resulting in pituitary necrosis, microinfarction, or hemorrhage have been suggested as potential mechanisms to explain how pregnancy might lead to normalization of prolactin (21)."
. Arch Sex Behav. 1998 Oct;27(5):475-92. In this study, transsexual women were given high dose intramuscular E and some were on medium-high dose oral E. In spite of this, there was not one incidence of prolactinoma.
"we detected no prolactinoma as described by other authors (Asscheman et al., 1988, 1989; Kovacs et al., 1994; Gooren et al., 1980)."
. In my extensive search through incidences of prolactinoma in transsexual women, the only incidences reported were found to be in those women who took high doses of non bio-identical forms of estrogen orally (ethinyl estradiol, equine estrogens) most often with high doses of cyproterone acetate, OR a combination of estradiol enanthate and dihydroxyprogesterone acetophenide, all known to
abnormally elevate prolactin levels (in the last case due to progestogen component). Incidences in women taking bio-identical estradiol without the above mentioned agents taken simultaneously have NEVER been reported to date. Incidences in male to female transsexuals are also RARE, only 8 cases reported in the literature as of 2015 despite sometimes very high doses of estrogen taken during several decades. Studies to support.
I'm POST-OP and on a high dose of intramuscular E. Supervised by three doctors who approve, one of whom is an author of a book on female hormones, another a trans-specialist endocrinologist from the University of Cambridge. My blood tests results show no change in clotting factors, or liver enzymes, or lipids, insulin, glucose, c-reactive protein. Nothing is out of range given my high levels of E2, which are in the range of 1,000-4,000 pg/ml. I've also been on high doses of oral bio-identical estradiol for several years. I started HRT in 2004.
I read from many other transwomen pre and post-op who have taken high doses of bio-identical E parenterally with high levels of E and their blood test results always came back normal. Most were above 40 yrs old.
As always, double check, do your own research, talk to doctors. I could be wrong, I'm not a doctor or specialist and could have missed something along the way.

Take care and all the best.

Quote from: kaitylynn on June 19, 2016, 08:38:40 AM
It is my understanding that the AA does nothing really for the development and that E (and P, if used) are the primary facilitators of our outward traits. I have seen men with prostate issues who use AA's and they do develop feminine traits over time, but nothing like what I have experienced in under a year.
The reason being they don't take E as well. But, in those taking bicalutamide especially and also in the case of cyproterone acetate, some breast growth is observed (up to 70-80%, according to wikipedia, other sources state up to 50%) as well as some degree of feminization.
E alone can have a significant impact on development but only if T is reduced sufficiently (in the vast majority of people) and sometimes, because pellets or injectables aren't available (or doctor refuses), an anti-androgen is necessary as orally, too high doses of E can sometimes be problematic, usually for the older population but this is subject to debate as well since I know some older transwomen who do well on high doses of oral bio E.
QuoteI have increases 2 cup sizes and have some pretty nice hips building and when my endo and I discussed things, she explained that E alone did this and that the T suppression really only helped my E receptors to "wake up" quicker.
Androgen is an inhibitor of feminization and its absence will trigger full feminization as is the case, for instance in individuals completely insensitive to androgen, despite their very low level of E, who develop breasts (often larger than ciswomen) and hips and are very feminine.
QuoteNo matter, a steady supply of E alone will lower T levels over time.
Depends on how much E and to what degree T is lowered.